Bill number does not exist. Enter a vaild keyword.
Facebook Twitter Youtube Channels

Committee Testimony and Witness Signup

HB0222 - County Boards of Education - Opioid Overdose-Reversing Medications - Policy Requirements (Naloxone Access Act)

Ways and Means 1/20/2026 1:00:00 PM
Education, Energy, and the Environment 4/1/2026 1:00:00 PM
As of: 5/17/2026 9:53:02 PM
Name Organization Position Testimony Committee
Delegate Vogel, Delegate Vogel FAV In Person - Oral Testimony
W&M
Rosen-Cohen, Nancy NCADD-Maryland FAV NCADD-MD - 2026 HB 222 FAV - Protecting Our Kids F W&M
Gannon, Michael FAV FAV_Testimony_Michael_Gannon.pdf W&M
Vogel, Joe Office of Delegate Joe Vogel FAV HB0222 Vogel Testimony.pdf W&M
Rabbitt, Dan Behavioral Health System Baltimore FAV HB 222_Nalxone Access Act_BHSB_FAVORABLE.pdf W&M
Keller, Emily Maryland's Office of Overdose Response FWA HB222- MOOR - LOSWA.pdf W&M
Cratsley, Laurel Maryland State Department of Education FWA HB 222 - SWA - State Board.pdf W&M
Kaplowitz, Richard KAP Year FAV Testimony in support of HB0222 - Educational Insti W&M
Mitchell, Laura Individual FWA Mitchell Laura TESTIMONY IN SUPPORT of HB222 Opioi W&M
Ball, Calvin FAV Howard County Executive W&M
Delegate Vogel, Delegate Vogel FAV In Person - Oral Testimony
EEE
Rhyne, Saan FAV HB222-SaanRhyne.pdf EEE
Burnett, Zoe American Youth Association and Hagerstown Youth Council FAV In Person - Oral Testimony
EEE
Rosen-Cohen, Nancy NCADD-Maryland FAV NCADD-MD - 2026 HB 222 FAV - Naloxone Access Act - EEE
Rabbitt, Dan Behavioral Health System Baltimore FAV HB 222 Crossover_Nalxone Access Act_BHSB_FAVORABLE EEE
Carter, Alita-Geri Qualequity Access FAV No Testimony EEE
Tibbals, Trudy UNF No Testimony EEE
Vogel, Joe Office of Delegate Joe Vogel FAV In Person - Oral Testimony
FINAL HB0222 Testimony (Senate).pdf
EEE
Keller, Emily Maryland's Office of Overdose Response FWA In Person - Oral Testimony
EEE-HB222- MOOR - LOSWA.pdf
EEE
Cratsley, Laurel Maryland State Department of Education FAV HB222 - State Board & MSDE - Support 4.1.26.docx. EEE
Kaplowitz, Richard KAP Year FAV HB0222 - crossover bill - FAV - Naloxone Access A EEE
Testimony, All N/A Merged Testimony as of 3-31-2026 at 1009 AM EEE
Click to return on the top page